stroke
Conditions
Interventions
Healthy Control Group:None
Test Group:None
Sponsors
Department of Rehabilitation Medicine, Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patient inclusion criteria: (1) Age between 18 and 80 years. (2) Not participating in other clinical studies within one week. (3) The stroke patients were first-onset, and the diagnosis was in accordance with the relevant criteria of the Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Disease. Patients have static or dynamic onset of the disease, and some of them have transient ischemic attack in the early stage; the disease reaches its peak in a few hours or a few days, and some of them have progressive aggravation or fluctuation of symptoms; the symptoms include hemiplegia, hemiparesis, ataxia and hemiparesis. Symptoms include hemiplegia, hemiparesis, ataxia, and in some cases, whole-brain symptoms such as coma, vomiting, and headache. The diagnosis was confirmed by blood and imaging tests. (4) Patients with a modified Rankin Scale score of =4; (5) The patients were able to participate in the whole study, and the patients or their family members gave informed consent to the study and signed the informed consent form. (5) The patient is able to participate in the entire study, and the patient or the patient's family has given informed consent to the study and signed the informed consent form. Inclusion criteria for healthy subjects: (1) Age between 18 and 80 years old. (2) Not participating in other clinical studies within one week. (3) Participation in the entire study, voluntary participation in the study, and signing of the informed consent form. consent form.
Exclusion criteria
Exclusion criteria: Patient exclusion criteria: (1) Cognitively abnormal individuals, subjects with psychiatric disorders, or patients with a family history of mental illness; (2) Allergic subjects or with severe primary cardiopulmonary, hepatic, renal, hematologic, or other life-threatening diseases; (3) Basic skin problems on the forehead, such as acne, breakouts, and allergic rashes; (4) Secondary insomnia due to somatic or other psychiatric disorders; (5) Participants who, in the opinion of the Chief Physician, are unfit to participate (e.g., respiratory failure) or who drop out midway through the study for some reason; (6) Patients who have taken coffee, tea, or alcohol within 24 hours prior to the study, or who have taken neurotoxic drugs such as sedative or hypnotic drugs 2 weeks prior to the study, or who have a history of drug or alcohol dependence; (7) Patients with a combination of severe respiratory, circulatory, and hematologic disorders, as well as moderate-to-severe diseases of other systems, and pneumonectomy; (8) Pregnant and lactating women. Exclusion criteria for healthy individuals: (1) Previous history of severe atrial fibrillation or cardiac surgery; (2) Previous history of mental illness; (3) Coffee, tea, or alcohol consumption within 24 hours prior to the study; (4) Taking neurotoxic drugs such as sedative or hypnotic drugs, or having a history of drug or alcohol dependence in the 2 weeks before the study; (5) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total sleep times;sleep structures;sleep efficiency;Sleep latency;sleep on waking time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep shuttle waves;sleep slow waves; | — |
Countries
China
Contacts
Public ContactWang Yulong
Shenzhen Second People's Hospital
Outcome results
None listed